India, July 22 -- A new study by researchers at the University of Texas Southwestern Medical Center, published in JAMA Pediatrics, found that more adolescents and young adults in the U.S. are using GLP-1 weight-loss drugs to treat obesity.
"This research is the first national-scale Epic Cosmos analysis, to our knowledge, to characterize real-world use of combined GLP-1RA therapy and MBS among adolescents and young adults with obesity," said lead author Sarah Messiah, professor of epidemiology and associate dean for research in the Peter O'Donnell Jr. School of Public Health at UT Southwestern.
To study this, they analyzed data from Epic Cosmos, a database containing more than 300 million patient records from thousands of hospitals and cli...